S&P 500   2,995.83 (+1.00%)
DOW   27,029.14 (+0.90%)
QQQ   193.49 (+1.26%)
AAPL   235.09 (-0.33%)
FB   188.94 (+3.09%)
MSFT   141.40 (+1.33%)
GOOGL   1,242.72 (+2.05%)
AMZN   1,768.01 (+1.82%)
CGC   20.07 (+6.42%)
NVDA   196.53 (+5.36%)
MU   46.50 (+3.66%)
BABA   175.37 (+2.46%)
TSLA   257.85 (+0.35%)
AMD   30.74 (+0.69%)
T   37.93 (+1.20%)
ACB   3.77 (+7.42%)
NFLX   283.90 (-0.57%)
BAC   29.82 (+2.33%)
GILD   65.36 (+1.32%)
DIS   129.80 (+0.08%)
S&P 500   2,995.83 (+1.00%)
DOW   27,029.14 (+0.90%)
QQQ   193.49 (+1.26%)
AAPL   235.09 (-0.33%)
FB   188.94 (+3.09%)
MSFT   141.40 (+1.33%)
GOOGL   1,242.72 (+2.05%)
AMZN   1,768.01 (+1.82%)
CGC   20.07 (+6.42%)
NVDA   196.53 (+5.36%)
MU   46.50 (+3.66%)
BABA   175.37 (+2.46%)
TSLA   257.85 (+0.35%)
AMD   30.74 (+0.69%)
T   37.93 (+1.20%)
ACB   3.77 (+7.42%)
NFLX   283.90 (-0.57%)
BAC   29.82 (+2.33%)
GILD   65.36 (+1.32%)
DIS   129.80 (+0.08%)
Log in

Novus Therapeutics SEC Filings & 10K Form (NASDAQ:NVUS)

$0.46
-0.03 (-6.12 %)
(As of 10/15/2019 04:00 PM ET)
Today's Range
$0.46
Now: $0.46
$0.50
50-Day Range
$0.50
MA: $0.68
$0.79
52-Week Range
$0.48
Now: $0.46
$5.21
Volume101,700 shs
Average Volume61,805 shs
Market Capitalization$5.97 million
P/E RatioN/A
Dividend YieldN/A
Beta2.86

SEC Filings

Novus Therapeutics (NASDAQ:NVUS) SEC Filings

DateFilerForm TypeView
09/30/2019
8:30 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
8:30 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
8:30 PM
FLESHER GREGORY J. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
4:30 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2019
1:48 PM
683 Capital Management, LLC (Filed by)
Novus Therapeutics (Subject)
Form SC 13G
07/15/2019
3:06 PM
McBride John S. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:05 PM
Katkin Keith (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:05 PM
Chimovits Erez (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:05 PM
LYONS GARY A (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:05 PM
Cohen Cheryl (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:05 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
3:08 PM
Novus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/17/2019
11:15 PM
Novus Therapeutics (Filer)
Form EFFECT
06/07/2019
3:07 PM
Novus Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/05/2019
1:59 PM
ARMISTICE CAPITAL, LLC (Filed by)
Novus Therapeutics (Subject)
Form SC 13G
05/22/2019
3:12 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:02 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:01 PM
FLESHER GREGORY J. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:33 PM
Novus Therapeutics (Filer)
Form DEFA14A
05/15/2019
3:30 PM
Novus Therapeutics (Filer)
Form DEF 14A
05/10/2019
3:24 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Novus Therapeutics (Subject)
Form SC 13G
05/10/2019
3:01 PM
Novus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
05/06/2019
4:30 PM
Novus Therapeutics (Issuer)
OrbiMed Israel BioFund GP Limited Partnership (Reporting)
OrbiMed Israel GP Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2019
4:28 PM
Chimovits Erez (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2019
4:01 PM
Novus Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
Form SC 13D/A
05/02/2019
3:47 PM
LIFESCI INDEX PARTNERS LLC (Reporting)
Novus Therapeutics (Issuer)
YOOK PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
3:24 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
5:07 AM
Novus Therapeutics (Filer)
Form 424B5
04/30/2019
3:05 PM
Novus Therapeutics (Filer)
Form 10-K/A
04/22/2019
7:02 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
6:32 AM
Novartis Bioventures Ltd (Filed by)
Novus Therapeutics (Subject)
Form SC 13D/A
03/28/2019
5:04 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
3:23 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
11:49 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
6:58 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2018
7:00 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2018
7:00 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2018
8:00 AM
Novus Therapeutics (Filer)
Form RW
09/04/2018
3:38 PM
Novus Therapeutics (Filer)
Form S-1/A
08/07/2018
7:31 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
11:15 PM
Novus Therapeutics (Filer)
Form EFFECT
07/23/2018
3:08 PM
Novus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/14/2018
4:54 PM
Cohen Cheryl (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:53 PM
LYONS GARY A (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:52 PM
Katkin Keith (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:52 PM
McBride John S. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:24 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
3:22 PM
APPLE TREE PARTNERS II LP (Filed by)
Novus Therapeutics (Subject)
Form SC 13D/A
04/30/2018
12:12 PM
Novus Therapeutics (Filer)
Form DEFA14A
04/30/2018
12:03 PM
Novus Therapeutics (Filer)
Form DEF 14A
04/17/2018
3:21 PM
Novartis Bioventures Ltd (Filed by)
Novus Therapeutics (Subject)
Form SC 13D/A
03/30/2018
8:54 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2018
8:46 PM
Novus Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2018
1:17 PM
LIFESCI INDEX PARTNERS LLC (Reporting)
Novus Therapeutics (Issuer)
YOOK PAUL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2018
2:16 PM
Novus Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
Form SC 13D/A
03/15/2018
5:53 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
5:51 PM
FLESHER GREGORY J. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
5:46 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
11:12 AM
LIFESCI INDEX PARTNERS LLC (Filed by)
Novus Therapeutics (Subject)
Form SC 13G
01/08/2018
4:11 PM
APPLE TREE PARTNERS II LP (Filed by)
Novus Therapeutics (Subject)
Form SC 13D/A
11/29/2017
4:00 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: Economic Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel